Drawing for KIYA THERAPEUTICS

USPTO serial 88337239

KIYA THERAPEUTICS

Reg. 6088331Status 700Renewal
Filing date
Mar 13, 2019
Status date
Jun 30, 2020
Registration date
Jun 30, 2020
Examiner
ALESKOW, DAVID HOWARD

Need help with KIYA THERAPEUTICS?

CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Deadline: June 30th, 2026

Owner

  • Rose, Brian James

    Chandler, AZ

  • ASHUR ENTERPRISES, INC.

    MESA, AZ

  • ASHUR ENTERPRISES, INC.

    MESA, AZ

  • ASHUR ENTERPRISES, INC.

    MESA, AZ

Goods and services

ClassDescriptionStatusFirst use
005Nutraceuticals for use as a dietary supplementACTIVEJun 25, 2018

Prosecution history

DateCodeEvent
Jun 30, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 30, 2020R.PRREGISTERED-PRINCIPAL REGISTER
Apr 14, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 14, 2020PUBOPUBLISHED FOR OPPOSITION
Mar 25, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 12, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Feb 28, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Feb 28, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 25, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 29, 2020ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Nov 19, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 19, 2019GNRTNON-FINAL ACTION E-MAILED
Nov 19, 2019CNRTNON-FINAL ACTION WRITTEN
Oct 25, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Oct 25, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 23, 2019ALIEASSIGNED TO LIE
Oct 20, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVED
May 23, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILED
May 23, 2019GNRTNON-FINAL ACTION E-MAILED
May 23, 2019CNRTNON-FINAL ACTION WRITTEN
May 23, 2019DOCKASSIGNED TO EXAMINER
Mar 30, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 16, 2019NWAPNEW APPLICATION ENTERED

Related guidance